Mid-term results of mitral valve repair for ischemic mitral regurgitation with ETlogix ring: A single-center study
| Autor: | Marco Vola, Jean François Fuzellier, Antoine Gerbay, Benjamain Haber, Salvatore Campisi, J.-P. Favre |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty Mitral Valve Annuloplasty Time Factors medicine.medical_treatment Myocardial Ischemia 030204 cardiovascular system & hematology Single Center Coronary Angiography Prosthesis Design Coronary artery disease 03 medical and health sciences 0302 clinical medicine Internal medicine Mitral valve medicine Humans 030212 general & internal medicine Survival rate Aged Retrospective Studies Surgical repair Mitral valve repair Mitral regurgitation business.industry Mitral Valve Insufficiency medicine.disease Surgery medicine.anatomical_structure Treatment Outcome Echocardiography Heart Valve Prosthesis Cardiology Mitral Valve Female Cardiology and Cardiovascular Medicine Complication business Follow-Up Studies |
| Zdroj: | International journal of cardiology. 222 |
| ISSN: | 1874-1754 |
| Popis: | Background Ischemic mitral regurgitation (IMR) is a common complication of coronary artery disease and represents an independent predictor of mortality. In the IMR the pattern of mitral valve annular dilatation is asymmetrical: this can explain the long-term incidence of recurrent mitral regurgitation after surgical annular size reduction with a symmetrical ring. The aim of this study is to analyze early and mid-term results of mitral valve repair (MVR) with the CMA IMR ETlogix ring, specifically developed for the surgical correction of IMR. Methods Retrospectively, we studied 157 consecutive patients who underwent MVR with the CMA ETlogix ring for the treatment of grade ≥ 2 IMR in our center between June 2006 and December 2012. We reported clinical and echocardiographic early and mid-term results of this surgical technique. Results Postoperative 30 days mortality was 6.3%. Postoperative echocardiography evaluation at discharge revealed the absence of residual MR in 70%, mild MR in 26.5% and moderate MR in 3.5% of patients respectively. Median echographic follow-up time was 28 (3–84) months: survival rate was 92.1% at 32 months; free from mitral valve reoperation rate was 97.5% and grade > 2 MR recurrence free survival rate was 96.6%. Conclusion There are a few reports in the literature concerning the mid-term results of IMR surgical correction with CMA Etlogix ring. Our study, taking into account a large series of patients and an important follow-up period, demonstrates the effectiveness of this surgical repair technique reporting a low mid-term incidence of recurrent MR. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect